Overview
BRKR market data
Price History
BRKR price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for BRKR. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Mass Spectrometry Market Size Worth USD 14.09 Billion by 2035 | SNS InsiderGlobenewswire Inc · Jul 17, 2026, 11:15 AM
Bruker Acquires The DISQVER Clinical Metagenomics Platform From Noscendo; Financial Terms Not DisclosedBenzinga · Jul 15, 2026, 11:05 AM
Citigroup Maintains Neutral on Bruker, Raises Price Target to $60Benzinga · Jul 8, 2026, 4:10 PM
Leerink Partners Maintains Outperform on Bruker, Raises Price Target to $70Benzinga · Jul 7, 2026, 6:00 PM
Spatial Genomics and Transcriptomics Market Size to Reach USD 1.90 Billion by 2035, Growing at a 12.23% CAGR | SNS InsiderGlobenewswire Inc · Jun 30, 2026, 12:15 PM
Guggenheim Maintains Buy on Bruker, Raises Price Target to $70Benzinga · Jun 29, 2026, 2:05 PM
Barclays Maintains Overweight on Bruker, Raises Price Target to $60Benzinga · Jun 24, 2026, 2:35 PM
Bruker Corp Files Prospectus For Mixed Shelf Offering, Size Not DisclosedBenzinga · Jun 12, 2026, 8:20 PM
Bruker's Microbiology & Infection Diagnostic Division Showcases Expanding Portfolio, Innovations Throughout Microbial Identification, Sepsis Diagnostics, Molecular Testing, And NGS WorkflowsBenzinga · Jun 4, 2026, 11:30 AM
Bruker Launches New Mass Spectrometry Platform For Petroleomics And Sustainable Fuels ResearchBenzinga · Jun 2, 2026, 3:28 PM